Correlation of FGG haplotypes with fibrinogen and fibrinogen γ′ content in juvenile VT subjects
| Haplotype . | n . | Fibrinogen . | γ′ content, % . | γ′ absolute . |
|---|---|---|---|---|
| H2/H2 | 26 | 285.1 ± 70.7 | 6.01 ± 2.25 | 17.30 ± 8.00 |
| H2/H1 | 48 | 297.6 ± 107.5 | 7.67 ± 3.19 | 23.82 ± 17.21 |
| H2/H3 | 30 | 291.6 ± 67.8 | 8.99 ± 2.73 | 26.56 ± 10.80 |
| H2/H4 | 6 | 293.8 ± 84.3 | 7.33 ± 2.83 | 20.56 ± 7.47 |
| H1/H1 | 29 | 316.1 ± 125.9 | 9.78 ± 2.95 | 30.76 ± 13.66 |
| H1/H3 | 33 | 253 ± 67.27 | 9.01 ± 3.89 | 23.08 ± 19.30 |
| H1/H4 | 11 | 296.0 ± 56.2 | 9.33 ± 3.60 | 27.21 ± 9.90 |
| H3/H3 | 19 | 275.6 ± 71.3 | 9.84 ± 3.15 | 27.19 ± 10.71 |
| H3/H4 | 3 | 253 ± 23.1 | 8.37 ± 4.13 | 20.61 ± 8.83 |
| FVLeiden-negative | ||||
| FGG-H2 | 83 | 282 ± 72 | 7.5 ± 3 | 21.4 ± 11 |
| Other | 72 | 279 ± 96 | 9.2 ± 3.1 | 25.9 ± 12 |
| H2 vs other, P | NS | .001 | .02 | |
| FVLeiden carrier | ||||
| FGG-H2 | 21 | 307 ± 125 | 7.5 ± 4 | 23.4 ± 19 |
| Other | 18 | 300 ± 75 | 11 ± 3 | 32.8 ± 11 |
| H2 vs other, P | NS | .002 | .06 |
| Haplotype . | n . | Fibrinogen . | γ′ content, % . | γ′ absolute . |
|---|---|---|---|---|
| H2/H2 | 26 | 285.1 ± 70.7 | 6.01 ± 2.25 | 17.30 ± 8.00 |
| H2/H1 | 48 | 297.6 ± 107.5 | 7.67 ± 3.19 | 23.82 ± 17.21 |
| H2/H3 | 30 | 291.6 ± 67.8 | 8.99 ± 2.73 | 26.56 ± 10.80 |
| H2/H4 | 6 | 293.8 ± 84.3 | 7.33 ± 2.83 | 20.56 ± 7.47 |
| H1/H1 | 29 | 316.1 ± 125.9 | 9.78 ± 2.95 | 30.76 ± 13.66 |
| H1/H3 | 33 | 253 ± 67.27 | 9.01 ± 3.89 | 23.08 ± 19.30 |
| H1/H4 | 11 | 296.0 ± 56.2 | 9.33 ± 3.60 | 27.21 ± 9.90 |
| H3/H3 | 19 | 275.6 ± 71.3 | 9.84 ± 3.15 | 27.19 ± 10.71 |
| H3/H4 | 3 | 253 ± 23.1 | 8.37 ± 4.13 | 20.61 ± 8.83 |
| FVLeiden-negative | ||||
| FGG-H2 | 83 | 282 ± 72 | 7.5 ± 3 | 21.4 ± 11 |
| Other | 72 | 279 ± 96 | 9.2 ± 3.1 | 25.9 ± 12 |
| H2 vs other, P | NS | .001 | .02 | |
| FVLeiden carrier | ||||
| FGG-H2 | 21 | 307 ± 125 | 7.5 ± 4 | 23.4 ± 19 |
| Other | 18 | 300 ± 75 | 11 ± 3 | 32.8 ± 11 |
| H2 vs other, P | NS | .002 | .06 |
NS indicates not significant.